Mollica V.; Rizzo A.; Rosellini M.; Marchetti A.; Ricci A.D.; Cimadamore A.; Scarpelli M.; Bonucci C.; Andrini E.; Errani C.; Santoni M.; Montironi R.; Massari F., Bone targeting agents in patients with metastatic prostate cancer: State of the art, «CANCERS», 2021, 13, Article number: 546, pp. 1 - 13 [articolo]Open Access
Rizzo A.; Mollica V.; Santoni M.; Rosellini M.; Marchetti A.; Ricci A.D.; Grilli G.; Greco A.; Montironi R.; Ardizzoni A.; Massari F., Comparative effectiveness of first-line immune checkpoint inhibitors plus tyrosine kinase inhibitors according to IMDC risk groups in metastatic renal cell carcinoma: A meta-analysis, «IMMUNOTHERAPY», 2021, 13, pp. 783 - 793 [articolo]
Rizzo A.; Rosellini M.; Marchetti A.; Mollica V.; Massari F., Determinants of treatment for first-line immune-based combinations in metastatic renal cell carcinoma: A critical overview of recent evidence, «IMMUNOTHERAPY», 2021, 13, pp. 685 - 692 [articolo]
Rizzo, Alessandro; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Ricci, Angela Dalia; Fiorentino, Michelangelo; Battelli, Nicola; Santoni, Matteo; Massari, Francesco, Exploring the association between metastatic sites and androgen receptor splice variant 7 (AR-V7) in castration-resistant prostate cancer patients: A meta-analysis of prospective clinical trials, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 222, Article number: 153440, pp. 153440 - 153446 [articolo]
Massari F.; Rizzo A.; Mollica V.; Rosellini M.; Marchetti A.; Ardizzoni A.; Santoni M., Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials, «EUROPEAN JOURNAL OF CANCER», 2021, 154, pp. 120 - 127 [articolo]
Massari, Francesco; Rizzo, Alessandro; Mollica, Veronica; Rosellini, Matteo; Marchetti, Andrea; Ardizzoni, Andrea; Santoni, Matteo, Immune-based combinations for the treatment of metastatic renal cell carcinoma: a meta-analysis of randomised clinical trials, «EUROPEAN JOURNAL OF CANCER», 2021, 154, pp. 120 - 127 [articolo]
Rizzo A.; Mollica V.; Santoni M.; Ricci A.D.; Rosellini M.; Marchetti A.; Montironi R.; Ardizzoni A.; Massari F., Impact of Clinicopathological Features on Survival in Patients Treated with First-line Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Renal Cell Carcinoma: A Meta-analysis of Randomized Clinical Trials, «EUROPEAN UROLOGY FOCUS», 2021, 1077, pp. 1 - 8 [articolo]
Rizzo, Alessandro; Mollica, Veronica; Giunchi, Francesca; Dall'Olio, Filippo Gustavo; Rosellini, Matteo; Marchetti, Andrea; Franceschini, Tania; Schiavina, Riccardo; Brunocilla, Eugenio; Fiorentino, Michelangelo; Ardizzoni, Andrea; Massari, Francesco, Impact of HER2 assessment by CISH in urothelial carcinoma: A retrospective single-center experience, «PATHOLOGY RESEARCH AND PRACTICE», 2021, 220, Article number: 153410, pp. 1 - 5 [articolo]
Rizzo A.; Santoni M.; Mollica V.; Logullo F.; Rosellini M.; Marchetti A.; Faloppi L.; Battelli N.; Massari F., Peripheral neuropathy and headache in cancer patients treated with immunotherapy and immuno-oncology combinations: the MOUSEION-02 study, «EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY», 2021, 17, pp. 1455 - 1466 [articolo]
Rizzo A.; Mollica V.; Dall'Olio F.G.; Ricci A.D.; Maggio I.; Marchetti A.; Rosellini M.; Santoni M.; Ardizzoni A.; Massari F., Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: A systematic review, «FUTURE ONCOLOGY», 2021, 17, pp. 2671 - 2681 [articolo]
Marchetti A.; Rosellini M.; Mollica V.; Rizzo A.; Tassinari E.; Nuvola G.; Cimadamore A.; Santoni M.; Fiorentino M.; Montironi R.; Massari F., The molecular characteristics of non‐clear cell renal cell carcinoma: What’s the story morning glory?, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 6237, pp. 6237 - 6237 [articolo]Open Access
Rosellini M.; Santoni M.; Mollica V.; Rizzo A.; Cimadamore A.; Scarpelli M.; Storti N.; Battelli N.; Montironi R.; Massari F., Treating prostate cancer by antibody-drug conjugates, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2021, 22, Article number: 1551, pp. 1 - 15 [articolo]Open Access
